These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 352339)

  • 1. Removal of non-specific antibodies from tetanus antitoxin serum by affinity chromatography using the antigens of a nontoxigenic derivative of Clostridium tetani.
    Hara T; Matsuda M; Yoneda M
    Biken J; 1977 Dec; 20(3-4):137-41. PubMed ID: 352339
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation and some properties of nontoxigenic derivatives of a strain of Clostridium tetani.
    Hara T; Matsuda M; Yoneda M
    Biken J; 1977 Dec; 20(3-4):105-15. PubMed ID: 352338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response of guinea pigs to fluid and adsorbed tetanus toxoids.
    Ahuja S; Sharma SB; Gupta RK; Maheshwari SC; Bhandari SK; Saxena SN
    Indian J Pathol Microbiol; 1986 Jul; 29(3):285-92. PubMed ID: 3546112
    [No Abstract]   [Full Text] [Related]  

  • 4. Transplacental antibodies. Part II: Maternal antibodies against the toxins of C. diphtheriae and C. tetani.
    Celko A; Burianová B; Kŕíz B; Zikmundová V; Zikmund V; Stríbrný J
    J Hyg Epidemiol Microbiol Immunol; 1985; 29(1):83-8. PubMed ID: 3921608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficiency of immunogenesis stimulator for obtaining hyperimmune antitetanus sera].
    Zimina OI; Isaeva SIa; Cherniavs'kyĭ
    Mikrobiol Zh; 1976; 38(6):747-9. PubMed ID: 794645
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of the immune response of inoculated and intact animals to the administration of toxigenic and nontoxigenic strains of Clostridium tetani].
    Shvarts SA; Stovbun SF; Bukova VE; Anisimova LA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):82-6. PubMed ID: 3518309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Airborn hyperimmunization and treatment of animals with hyperimmune serum. 1. Studies on airborn hyperimmunization of horses using tetanus antigen and on treatment with tetanus hyperimmune serum].
    Schützler H; Dockhorn W
    Arch Exp Veterinarmed; 1972; 26(1):11-24. PubMed ID: 4560559
    [No Abstract]   [Full Text] [Related]  

  • 8. A study on the composition of the toxin-antiserum flocculates of two Cl. tetani strains.
    Yomtov M; Solomonova K; Valchev V
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Apr; 132(4):368-77. PubMed ID: 4232421
    [No Abstract]   [Full Text] [Related]  

  • 9. Horse products for tetanus prophylaxis.
    Shindman J
    CMAJ; 1994 Jul; 151(1):16. PubMed ID: 8004555
    [No Abstract]   [Full Text] [Related]  

  • 10. A REPRODUCIBLE METHOD FOR THE REMOVAL OF NON-SPECIFIC FLOCCULATING ANTIBODIES FROM TETANUS ANTITOXIN SERUM.
    TSUNASHIMA I; SATO K; SHOJI K; YONEDA M; AMANO T
    Biken J; 1964 Dec; 7():137-52. PubMed ID: 14305995
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of clinical tetanus in a patient with protective antitetanus antibody level.
    Beltran A; Go E; Haq M; Clarke HB; Zaman M; Recco RA
    South Med J; 2007 Jan; 100(1):83. PubMed ID: 17269536
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immune response in active-passive immunization against tetanus].
    Bozović M
    Med Pregl; 1986; 39(7-8):327-9. PubMed ID: 3547064
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of drugs on the results of passive hemagglutination test].
    Metelitsa LA; Mogilevich SE; Luĭk AI
    Klin Lab Diagn; 1996; (2):46-7. PubMed ID: 8680776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of tetanus antitoxin in human serum].
    Kamenická L; Masár I; Nováková I
    Cesk Epidemiol Mikrobiol Imunol; 1984 May; 33(3):136-41. PubMed ID: 6235929
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tetanus prevention: difficulties and errors].
    Mach B; Caban J
    Pol Przegl Chir; 1976 Apr; 48(4):535-9. PubMed ID: 775471
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of administration of blood products on the course of tetanus antibody concentration in immuno-incompetent patients].
    Pietsch M; Töre S; Schütt KH
    Infusionsther Transfusionsmed; 1996 Feb; 23(1):25-8. PubMed ID: 8653012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in tetanus antibody levels after the administration of tetanus antigen in children].
    Domorázková E
    Cesk Pediatr; 1988 Apr; 43(4):209-11. PubMed ID: 3293813
    [No Abstract]   [Full Text] [Related]  

  • 18. [Importance of monitoring specific antibody serum titers for optimal passive immune protection in the tetanic patient].
    Pitzurra M; Calderazzo AB; Marconi P; Bastianini L; Pitzurra L; Biasini E
    Minerva Anestesiol; 1983 Oct; 49(10):597-604. PubMed ID: 6363975
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antigen localization at the ultrastructural level in Clostridium tetani].
    Vaĭsman ISh; Postanogova GV; Chemurzieva NV
    Izv Akad Nauk SSSR Biol; 1987; (4):596-606. PubMed ID: 3312353
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of chromatography for the preparation of homologous tetanus antitoxin.
    Alyoshkin VA; Borisova VN; Ponomaryova AM; Popkov MYu
    J Chromatogr; 1990 Nov; 520():425-31. PubMed ID: 1707888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.